Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Hidradenitis suppurativa improves with antiandrogen therapy.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

Hair loss in males and females is influenced by immune cell interactions, with potential treatments identified.

In PCOS, high male hormones cause hair growth, acne, and hair loss, affecting periods.

Men with early hair loss may have higher health risks similar to women with PCOS.

Androgenetic alopecia is more common in males, can be influenced by lifestyle, and may be linked to other skin issues.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Hormonal imbalances are important in the development of male pattern baldness.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.